Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DHPG

Product Specifications

Product Name Alternative

(RS)-3,5-DHPG

UNSPSC Description

DHPG ((RS)-3,5-DHPG) is an amino acid, which acts as a selective and potent agonist of group I mGluR (mGluR 1 and mGluR 5), shows no effect on Group II or Group III mGluRs[1]. DHPG ((RS)-3,5-DHPG) is also an effective antagonist of mGluRs linked to phospholipase D[2].

Target Antigen

mGluR

Type

Reference compound

Related Pathways

GPCR/G Protein;Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/dhpg.html

Purity

99.65

Solubility

DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 1 mg/mL (ultrasonic)

Smiles

O=C(O)C(N)C1=CC(O)=CC(O)=C1

Molecular Weight

183.163

References & Citations

[1]Winder DG, et al. Metabotropic glutamate receptor (mGluR)-mediated potentiation of cyclic AMP responses does not require phosphoinositide hydrolysis: mediation by a group II-like mGluR. J Neurochem. 1995 Feb;64(2):592-9.|[2]Pellegrini-Giampietro DE, et al. Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus. Br J Pharmacol. 1996 Jun;118(4):1035-43.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, stored under nitrogen)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-12598A/DHPG-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-12598A/DHPG-SDS-MedChemExpress.pdf

Clinical Information

No Development Reported

CAS Number

146255-66-5

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
MBS6381657-01 0.1 mL

HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight

Ask
View Details
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
MBS6381657-02 5x 0.1 mL

HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight

Ask
View Details
Recombinant VEGF Co Regulated Chemokine 1 (VCC1)
RPU58710-01 50 µg

Recombinant VEGF Co Regulated Chemokine 1 (VCC1)

Ask
View Details
Recombinant VEGF Co Regulated Chemokine 1 (VCC1)
RPU58710-02 100 µg

Recombinant VEGF Co Regulated Chemokine 1 (VCC1)

Ask
View Details
Recombinant VEGF Co Regulated Chemokine 1 (VCC1)
RPU58710-03 1 mg

Recombinant VEGF Co Regulated Chemokine 1 (VCC1)

Ask
View Details
ZDHHC16 (NM_198043) Human Over-expression Lysate
LH16120V 100 µg

ZDHHC16 (NM_198043) Human Over-expression Lysate

Ask
View Details